[{"NetIncomeLoss_1_Q3_USD":-36122000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":44972085.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":45119885.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":16219000.0,"RepaymentsOfDebtAndCapitalLeaseObligations_3_Q3_USD":5000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":245000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":45976000.0,"Depreciation_3_Q3_USD":317000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":15136000.0,"AssetsCurrent_0_Q3_USD":381745000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":7357000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7601558.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":7642000.0,"CommonStockSharesIssued_0_Q3_shares":44760513.0,"Assets_0_Q3_USD":480736000.0,"ShareBasedCompensation_3_Q3_USD":21213000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":75542000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":52467000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":15036000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-1518000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":813000.0,"CommonStockSharesAuthorized_0_Q3_shares":490000000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":19132000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ResearchAndDevelopmentExpense_3_Q3_USD":70033000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":29306000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":129791000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":235000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-349000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":120000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-98000.0,"CommonStockValue_0_Q3_USD":5000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":101096000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":134148000.0,"MarketableSecuritiesCurrent_0_Q3_USD":88865000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":380500000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_3_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-86278000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-36471000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1616000.0,"OtherAssetsNoncurrent_0_Q3_USD":8866000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":291585000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":76307000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":526174000.0,"Liabilities_0_Q3_USD":198956000.0,"OperatingLeaseLiability_0_Q3_USD":77324000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1095000.0,"OperatingIncomeLoss_3_Q3_USD":-89165000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_3_Q3_USD":0.0,"RestrictedCashNoncurrent_0_Q3_USD":11015000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":86317000.0,"AmortizationOfFinancingCosts_3_Q3_USD":36000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":235000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-349000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":206000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":8241000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-56409000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":4617000.0,"LiabilitiesCurrent_0_Q3_USD":22505000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_3_Q3_USD":1034000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":90663000.0,"InterestExpense_3_Q3_USD":19000.0,"InterestExpense_1_Q3_USD":6000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":1295000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1692000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":265000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":3654000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":302600000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":3568000.0,"NetIncomeLoss_3_Q3_USD":-86513000.0,"AccountsPayableCurrent_0_Q3_USD":5269000.0,"OperatingIncomeLoss_1_Q3_USD":-36663000.0,"CommonStockSharesOutstanding_0_Q3_shares":44760513.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":145000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q3_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":88865000.0,"InvestmentIncomeInterest_3_Q3_USD":2551000.0,"InvestmentIncomeInterest_1_Q3_USD":645000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":480736000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":3106000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":21213000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":8241000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-244644000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":90400000.0,"OperatingExpenses_3_Q3_USD":89165000.0,"OperatingExpenses_1_Q3_USD":36663000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":7566000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":75545000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.92,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.8,"OtherLiabilitiesNoncurrent_0_Q3_USD":267000.0,"StockholdersEquity_0_Q3_USD":281780000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1855000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1017000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":290000.0,"Ticker":"KOD","CIK":"1468748","name":"KODIAK SCIENCES INC.","OfficialName":"Kodiak Sciences Inc Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"350038530.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]